496 related articles for article (PubMed ID: 10533583)
1. Ionic targets for drug therapy and atrial fibrillation-induced electrical remodeling: insights from a mathematical model.
Courtemanche M; Ramirez RJ; Nattel S
Cardiovasc Res; 1999 May; 42(2):477-89. PubMed ID: 10533583
[TBL] [Abstract][Full Text] [Related]
2. Rate-Dependent Role of I
Aguilar M; Feng J; Vigmond E; Comtois P; Nattel S
Biophys J; 2017 May; 112(9):1997-2010. PubMed ID: 28494969
[TBL] [Abstract][Full Text] [Related]
3. Synergistic Anti-arrhythmic Effects in Human Atria with Combined Use of Sodium Blockers and Acacetin.
Ni H; Whittaker DG; Wang W; Giles WR; Narayan SM; Zhang H
Front Physiol; 2017; 8():946. PubMed ID: 29218016
[TBL] [Abstract][Full Text] [Related]
4. Potassium Channel Blockade Enhances Atrial Fibrillation-Selective Antiarrhythmic Effects of Optimized State-Dependent Sodium Channel Blockade.
Aguilar M; Xiong F; Qi XY; Comtois P; Nattel S
Circulation; 2015 Dec; 132(23):2203-11. PubMed ID: 26499964
[TBL] [Abstract][Full Text] [Related]
5. In silico study on the effects of IKur block kinetics on prolongation of human action potential after atrial fibrillation-induced electrical remodeling.
Tsujimae K; Murakami S; Kurachi Y
Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H793-800. PubMed ID: 18055524
[TBL] [Abstract][Full Text] [Related]
6. Role of IKur in controlling action potential shape and contractility in the human atrium: influence of chronic atrial fibrillation.
Wettwer E; Hála O; Christ T; Heubach JF; Dobrev D; Knaut M; Varró A; Ravens U
Circulation; 2004 Oct; 110(16):2299-306. PubMed ID: 15477405
[TBL] [Abstract][Full Text] [Related]
7. Role of up-regulation of IK1 in action potential shortening associated with atrial fibrillation in humans.
Zhang H; Garratt CJ; Zhu J; Holden AV
Cardiovasc Res; 2005 Jun; 66(3):493-502. PubMed ID: 15914114
[TBL] [Abstract][Full Text] [Related]
8. Can inhibition of IKur promote atrial fibrillation?
Burashnikov A; Antzelevitch C
Heart Rhythm; 2008 Sep; 5(9):1304-9. PubMed ID: 18774108
[TBL] [Abstract][Full Text] [Related]
9. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation.
Yue L; Feng J; Gaspo R; Li GR; Wang Z; Nattel S
Circ Res; 1997 Oct; 81(4):512-25. PubMed ID: 9314832
[TBL] [Abstract][Full Text] [Related]
10. The new antiarrhythmic drug vernakalant: ex vivo study of human atrial tissue from sinus rhythm and chronic atrial fibrillation.
Wettwer E; Christ T; Endig S; Rozmaritsa N; Matschke K; Lynch JJ; Pourrier M; Gibson JK; Fedida D; Knaut M; Ravens U
Cardiovasc Res; 2013 Apr; 98(1):145-54. PubMed ID: 23341576
[TBL] [Abstract][Full Text] [Related]
11. The Contribution of Ionic Currents to Rate-Dependent Action Potential Duration and Pattern of Reentry in a Mathematical Model of Human Atrial Fibrillation.
Lee YS; Hwang M; Song JS; Li C; Joung B; Sobie EA; Pak HN
PLoS One; 2016; 11(3):e0150779. PubMed ID: 26964092
[TBL] [Abstract][Full Text] [Related]
12. Pathology-specific effects of the IKur/Ito/IK,ACh blocker AVE0118 on ion channels in human chronic atrial fibrillation.
Christ T; Wettwer E; Voigt N; Hála O; Radicke S; Matschke K; Várro A; Dobrev D; Ravens U
Br J Pharmacol; 2008 Aug; 154(8):1619-30. PubMed ID: 18536759
[TBL] [Abstract][Full Text] [Related]
13. Revealing kinetics and state-dependent binding properties of I
Ellinwood N; Dobrev D; Morotti S; Grandi E
Chaos; 2017 Sep; 27(9):093918. PubMed ID: 28964116
[TBL] [Abstract][Full Text] [Related]
14. Characterization of an ultrarapid delayed rectifier potassium channel involved in canine atrial repolarization.
Yue L; Feng J; Li GR; Nattel S
J Physiol; 1996 Nov; 496 ( Pt 3)(Pt 3):647-62. PubMed ID: 8930833
[TBL] [Abstract][Full Text] [Related]
15. Theoretical possibilities for the development of novel antiarrhythmic drugs.
Varró A; Biliczki P; Iost N; Virág L; Hála O; Kovács P; Mátyus P; Papp JG
Curr Med Chem; 2004 Jan; 11(1):1-11. PubMed ID: 14754422
[TBL] [Abstract][Full Text] [Related]
16. Ionic mechanisms of electrical remodeling in human atrial fibrillation.
Bosch RF; Zeng X; Grammer JB; Popovic K; Mewis C; Kühlkamp V
Cardiovasc Res; 1999 Oct; 44(1):121-31. PubMed ID: 10615396
[TBL] [Abstract][Full Text] [Related]
17. Novel approaches for pharmacological management of atrial fibrillation.
Ehrlich JR; Nattel S
Drugs; 2009; 69(7):757-74. PubMed ID: 19441867
[TBL] [Abstract][Full Text] [Related]
18. Ultrarapid Delayed Rectifier K
Hilderink S; Devalla HD; Bosch L; Wilders R; Verkerk AO
Front Cell Dev Biol; 2020; 8():536. PubMed ID: 32850774
[TBL] [Abstract][Full Text] [Related]
19. Effects of flecainide, quinidine, and 4-aminopyridine on transient outward and ultrarapid delayed rectifier currents in human atrial myocytes.
Wang Z; Fermini B; Nattel S
J Pharmacol Exp Ther; 1995 Jan; 272(1):184-96. PubMed ID: 7815332
[TBL] [Abstract][Full Text] [Related]
20. Potential ionic mechanism for repolarization differences between canine right and left atrium.
Li D; Zhang L; Kneller J; Nattel S
Circ Res; 2001 Jun; 88(11):1168-75. PubMed ID: 11397783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
